SeaStar Medical is trading 6.13% up at $3.29, with no clear company-specific catalyst identified for September 10, 2026.

  • The latest investor-relations activity located was dated August 12.
  • No new filing, FDA update, announcement, or other major event was identified explaining the move.
  • Broader markets were lower, so the gain does not clearly track overall market direction.